– UK, Leeds – EMIS Group Plc (LON: EMIS), the UK leader in connected healthcare software and services, today announces the retirement of Robin Taylor and the appointment of Jennifer Byrne to the Board as an independent Non-executive Director.
Robin will retire at the conclusion of the 2019 Annual General Meeting on 8 May 2019, after nine years of service with EMIS Group as Senior Non-executive Independent Director and Chair of its audit committee.
Andy McKeon, Non-executive Director, who has been on the Board since 2013 will step up to the role of Senior Independent Director, while Kevin Boyd, Non-executive Director, will become Chair of the audit committee.
Jennifer Byrne will be formally appointed as an independent Non-executive Director immediately following the 2019 AGM on 8 May 2019, bringing her wealth of experience in the global software sector to the leadership team. She will join the EMIS Group Board’s audit, remuneration and nomination committees.
Mike O’Leary, Chairman of EMIS Group, said: “Robin has completed nine years of service with EMIS Group and on behalf of his colleagues, I would like to thank him sincerely for his advice and continued support throughout. We wish him a long and happy retirement.
Mike O’Leary, added: “It gives me great pleasure to welcome Jennifer Byrne to the Board. Her wealth of commercial experience and background in using technical insight to deliver challenging and technically complex engineering programmes will complement and enhance the significant expertise we already have on the Board.”
About Jennifer Byrne
Jennifer served Lockheed Martin for over twenty-five years in a series of high ranking roles including Vice President of Space Systems Engineering and Technology where her staff numbered in excess of 10,000. She has extensive experience of successful delivery of large scale mission critical products, projects and systems in highly complex environments. More recently, Jennifer relocated to the UK to take on the position of Chief Operating Officer at G-Research, a quantitative research, and technology company that produces predictive research and builds advanced data analytics technology.
About EMIS Group
EMIS Group is the UK leader in connected healthcare software and services. Its solutions are widely used across every major UK healthcare setting from primary, community & acute care, to high street pharmacies. EMIS Group helps healthcare professionals in over 10,000 organisations share vital information, facilitating better, more efficient healthcare and supporting longer and healthier lives.
EMIS Group serves the following healthcare markets under the EMIS Health brand:
Primary, Community & Acute Care, as the UK leader in clinical management systems for healthcare providers and commissioners. EMIS Health products, including the flagship EMIS Web, hold over 40 million patient records and are used by more than 100,000 professionals in nearly 6,000 healthcare organisations.
Community Pharmacy, with the UK’s single most used integrated community pharmacy and retail system.
These markets are also supported by other EMIS Group businesses:
under the Patient brand, the UK’s leading independent provider of patient-centric medical and wellbeing information and related transactional services.
under the Egton brand, providing specialist ICT infrastructure, hardware and engineering services, and non-clinical software into health and social care.
under the Dovetail Lab brand, a health technology company developing blockchain software to facilitate the integration of healthcare data.
For more information: https://www.emisgroupplc.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
